Authority Delegated for Clinical Laboratory Provisions
04/27/2004
Federal Register Delegation of Authority: HHS secretary Tommy Thompson, Secretary delegates to the FDA commissioner the authority to implement the Clinical Laboratory Improvements Amendments (CLIA) complexity categorization provisions as they apply to commercially available tests. This authority includes, but is not limited to the following:(a) Interpreting the CLIA provisions related to complexity categorization; (b) Holding public workshops and meetings on CLIA complexity categorization; and, (c) Developing and issuing implementing rules and guidance for CLIA complexity categorization. To view this delegation, click here.
